Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

Author： Plodkowski Raymond A   Nguyen Quang   Sundaram Umasankari   Nguyen Loida   Chau Diane L   St Jeor Sachiko  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.6, 2009-04, pp. : 1069-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug safety evaluation of naltrexone/bupropion for the treatment of obesity

By Verpeut Jessica L   Bello Nicholas T  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 831-841

Informa Healthcare

Access to resources Recommend Favorite

A Review on the Use of Statins and Tocotrienols, Individually or in Combination for the Treatment of Osteoporosis

By  

Current Drug Targets, Vol. 14, Iss. 13, 2013-12 ,pp. : 1579-1590

Bentham Science Publishers

Access to resources Recommend Favorite

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR

By  

Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

Bupropion: A Review of its Use in the Management of Smoking Cessation

By Holm K.J.   Spencer C.M.  

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 1007-1024

Adis International

Access to resources Recommend Favorite

Behavioral Treatment ++ Naltrexone Reduces Drug Use and Legal Problems in the Republic of Georgia

By Kirtadze Irma   Otiashvili David   O’Grady Kevin E.   Jones Hendrée E.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 2, 2012-03 ,pp. : 171-175

Informa Healthcare

Access to resources Recommend Favorite